Bunyavax

BunyaVax is a Dutch biotechnology company specializing in the development of next-generation vaccines against emerging infectious diseases, specifically those caused by viruses in the Bunyavirales order. The company utilizes a proprietary plug-and-play vaccine platform based on recombinant protein technology that mimics the structure of native virus particles to elicit potent immune responses. Their pipeline focuses on high-priority pathogens with pandemic potential, including Rift Valley fever virus and Crimean-Congo hemorrhagic fever virus. BunyaVax aims to provide rapid-response solutions for both human and veterinary health to combat zoonotic threats.